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Abstract: It is already known that progressive degeneration of cholinergic neurons in brain areas such as the hippocam-
pus and the cortex leads to memory deficits, as observed in Alzheimer’s disease. This work verified the effects of the infu-
sion of amyloid- (A) peptide associated to an attentional rehearsal on the density of 7 nicotinic cholinergic receptor 
(nAChR) in the brain of male Wistar rats. Animals received intracerebroventricular infusion of A or vehicle (control - C) 
and their attention was stimulated weekly (Stimulated A group: S-A and Stimulated Control group: SC) or not (Non-
Stimulated A group: N-SA and Non-Stimulated Control group: N-SC), using an active avoidance apparatus. Condi-
tioned avoidance responses (CAR) were registered. Chronic infusion of A caused a 37% reduction in CAR for N-SA. 
In S-A, this reduction was not observed. At the end, brains were extracted and autoradiography for 7 nAChR was con-
ducted using [125I]--bungarotoxin. There was an increase in 7 density in hippocampus, cortex and amygdala of SA 
animals, together with the memory preservation. In recent findings from our lab using mice infused with A and the 7 
antagonist methyllycaconitine, and stimulated weekly in the same apparatus, it was observed that memory maintenance 
was abolished. So, the increase in 7 density in brain areas related to memory might be related to a participation of this 
receptor in the long-lasting change in synaptic plasticity, which is important to improve and maintain memory consolida-
tion. 
Keywords: Alpha7 nicotinic receptor, amygdala, amyloid-, attention, hippocampus, memory, rehearsal. 
INTRODUCTION 
 The involvement of the cholinergic system with cognitive 
processes has already been established. Activation of this 
system has been particularly involved in the amplification of 
long-term potentiation (LTP) induction [1-3] and, conse-
quently, has been linked to learning and memory consolida-
tion [4-6]. Particularly, 7 nicotinic cholinergic receptors 
(nAChR) have been recently implicated in hippocampal ac-
tivity [7], memory reconsolidation [8] and sustained atten-
tion [9-11]. 
 In some degenerative processes, like Alzheimer’s disease 
(AD), the cholinergic transmission is critically affected, 
which currently makes the anticholinesterase agents the 
pharmacological therapy of choice throughout the world [12-
14]. Some studies have shown that activation of the cho-
linergic system in the hippocampus or in the amygdala 
maylead to cognitive adjustments related to emotional situa-
tions [15, 16]. This emotional-linked generated learning is  
 
*Address correspondence to this author at the School of Arts, Sciences and 
Humanities, Universidade de Sao Paulo, Av. Arlindo Bettio, 1000, Sao 
Paulo, SP, 03828-080, Brazil; Tel: +55-11-3091-1027; 
Fax: 55-11-3331-2008; E-mail: taniaviel@usp.br 
associated to fear conditioning, which consists of a stressful 
process in which one learns to associate a stimulus with an 
eminent danger [17, 18], and keeps attention high to avoid 
danger. The acquisition and storage of information generated 
by fear conditioning can be related to LTP in the amygdala 
[18, 19]. Recently, it has been demonstrated that some of the 
nicotine-induced facilitation of LTP in this area is mediated 
by activation of NMDA glutamatergic receptors [20]. In ad-
dition to this mechanism, activation of nACh receptors lo-
cated in GABAergic interneurons reduces the inhibition 
promoted by this system in the amygdala neurons, which in 
turn facilitates the activation of the glutamatergic system, 
and enhances LTP.  
 The density of 7 nACh receptors in the amygdala is 
greater than 42 density [21]. Also, functional nACh recep-
tors in some amygdala nuclei (like the basolateral complex) 
are predominantly 7-containing receptors [22]. These re-
ceptors are believed to play an antiinflammatory and neuro-
protective role in neurodegenerative diseases and in stressful 
situations [23-25]. Concerning these observations, the aim of 
this work was to determine the density of 7 nicotinic recep-
tors in the hippocampus, cortex and amygdala of rats submit-
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ted to the infusion of A peptide and correlate this with sus-
tained attention.  
MATERIAL AND METHODS 
Animals 
 Adult male Wistar rats (200 - 250 g body weight), pro-
vided from our own breeding colony, were kept in controlled 
room temperature (22-24 °C) and humidity (55-65%), with 
food and water ad libitum in a 12-hour-light/dark cycle. All 
the surgery and care procedures were strictly performed ac-
cording to the guidelines for animal experimentation as 
stipulated in the Guide for the Care and Use of Laboratory 
Animals (National Institute of Health Publication number 
86-23, Bethesda, MD) and The Ethics Committee on Ex-
perimental Research from Faculdade de Ciencias Medicas da 
Santa Casa de Sao Paulo, Brazil. All efforts were made to 
minimize the number of animals used and their level of suf-
fering.  
Behavioral tests
 The active avoidance apparatus was used to evaluate 
memory evocation and also to stimulate the alert and sus-
tained attention of the animals. Animals were selected ac-
cording to their ability to learn and memorize a task [26]. 
The trials were performed in a two-way shuttle-box (Ugo 
Basile, Comerio, Italy) consisting of two compartments ac-
cessible to each other by a hole in the wall. Each animal was 
placed individually and then acclimated to the shuttle-box 
apparatus for 5 min before each session. The animal was 
then subjected to 50 trials of avoidance conditioning (acqui-
sition test). Each trial consisted on 2 s conditioned stimulus 
(CS), i.e., a buzzer (70 dB, 760 Hz) and light, followed by 4 
s unconditioned stimulus (UCS), such as a scramble shock of 
0.5 mA delivered through the floor grid. Each trial was sepa-
rated by fixed intertrial intervals (20 s). During the acquisi-
tion session, the number of conditioned avoidance responses 
(CAR), in which the animals moved to the other compart-
ment of the shuttle-box before the beginning of the UCS, 
was recorded. All tests were carried out during the light 
phase (9:00 - 15:00 hr). In order to ensure that all animals 
submitted to the experiment had the same level of acquired 
memory, after one week (Test 1) animals were submitted 
again to the same protocol and those that reached a satisfac-
tory learning performance - i.e., those achieving CAR rates 
between 30% and 70% [26] - were divided into four groups 
and submitted to the surgical procedures: 1) Non-stimulated 
control (N-SC, n = 5): animals infused with vehicle and left 
in cages with no stimulus; 2) Non-stimulated A (N-SA, n 
= 6): animals infused with human 1-40 -amyloid peptide + 
E-64 and left in cages with no stimulus; 3) Stimulated con-
trol (SC, n = 6): animals infused with vehicle (Hepes, 4 mM, 
pH 8.0) and submitted weekly to the same experimental 
protocol during the infusion period; 4) Stimulated A (SA, 
n = 7): animals infused with human 1-40 -amyloid peptide 
+ E-64 and submitted weekly to the same experimental 
protocol during the A infusion period. Weekly rehearsal 
was used to improve the sustained attention. The 
experimental design is showed in the timeline below: 
Surgery 
 Selected animals were submitted to surgery for the im-
plantation of mini-osmotic pumps (Alzet, model 2004, 
Cupertino, CA, USA) filled up with either the vehicle (4 mM 
HEPES, pH 8.0 - stimulated or non-stimulated control 
group) plus 0.8 g E-64 or human (1-40) amyloid- peptide 
(20 g - stimulated and non-stimulated A group) plus 0.8 
g E-64, following a method previously described [27]. E-64 
is a cystein protease inhibitor known for increasing neurode-
generation caused by A infusion [26-29]. Briefly, after an-
esthesia with equitesin (4.25% chloral hydrate, 2.25% mag-
nesium sulphate, 42.6%, propylene glycol 11.5% alcohol, 
1% thiopental), a stainless steel cannula (Brain kit 1, Alzet, 
Cupertino, CA, USA) was implanted in the animal’s lateral 
ventricle using a stereotaxic instrument at coordinates: -0.8 
mm anteroposterior, -1.4 mm mediolateral to bregma, and -
3.5 mm dorsoventral to cranium [30]. The other extremity of 
the cannula was attached to a polyvinylchloride catheter 
(Medical grade, OD=1.14 mm, ID=0.69 mm) connected to 
the mini-osmotic pump that was subcutaneously implanted in 
the dorsum of the animal’s neck. The contents of the mini-
osmotic pumps were delivered at a flow of 0.25 L/hour, 
having a total volume of 200 L, according to the manufac-
turer guidelines. 
 Five weeks later, the animals were anesthetized with CO2 
saturation, killed by decapitation and the brains were re-
moved and immediately frozen in dimethylbutane at -50°C 
and stored at -80°C until use. 
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Autoradiography for 7 nAChR 
 The method used was based on a previously described 
procedure [31]. Serial sections of brains (20 m) were cut on 
a cryostat chamber (-20°C to -22°C, Microm HM 505 N, 
Francheville, France), thaw-mounted on gelatin-coated 
slides, desiccated for 5 min at room temperature and kept at -
80°C until use. 
 Sections were brought to room temperature (22ºC) and 
air dried (5 -10 minutes). Incubations were conducted for 90 
min at room temperature using 5 nM [125I]--bungarotoxin 
([125I]- -BUTX, 143.2 Ci/mmol). This concentration of ra-
dioligand was based on previous studies in the rat brain (data 
not shown) and corresponds to the Bmax value. Specific 
binding of the toxin for 7 nAChR, in this concentration, 
accounted for 80.2% of the total binding. Non-specific bind-
ing was assessed using 2 M of the unlabelled toxin. The 
radioligand was diluted in 50 mM phosphate buffer contain-
ing 1 mM ethilenediethil-tetra-acetic acid (EDTA) and 1 mM 
phenyl-methil-sulphonyl fluoride (PMSF), pH 7.4. At the 
end of the incubation period, slides were sequentially trans-
ferred through four rinses of 4 min each in the same buffer at 
4 °C and rapidly dipped into cold distilled water to remove 
excess salts. Sections were air-dried and juxtaposed against 
Hyperfilm-MP (double-coated, 24 x 30 cm, Amersham Bio-
sciences GE Healthcare, Uppsala, Sweden) for 14 days 
(room temperature), along with autoradiographic [125I] micro 
scales (20 m, Amersham Biosciences GE Healthcare). The 
films were developed in D-19 Kodak developer and fixed in 
Kodak Ektaflo solution.  
Quantification of receptor binding sites 
 The autoradiograms were quantified densitometrically 
using the MCID image analysis system (Interfoccus Europe, 
UK). For each specimen, 7 receptors binding sites were 
measured on 6 - 12 sections. The specific binding was de-
termined by subtracting the non-specific binding from the 
total binding of adjacent sections.  
Drugs 
 Human (1-40) amyloid- peptide was purchased from 
TOCRIS COOKSON INC, Ellisville, MO, USA, Na 125I--
BUTX from PERKIN-ELMER (Boston, MA, USA) and 
[125I]--bungarotoxin from SIGMA. All other drugs used 
were of analytical grade. 
Statistical analysis 
 Results were expressed as means ± S.E.M. and analyzed 
using one-way analysis of variance (ANOVA) for multiple 
comparisons. The difference among treatments was analyzed 
using the post-test of Tukey-Kramer, as follows: Treatment 
1: infusion of A in non-stimulated animals (comparison 
between N-SA and N-SC); Treatment 2: influence of atten-
tion training (comparison between SC and N-SC); Treatment 
3: infusion of A and attention training (comparison of SA 
with N-SA  and SA with SC.  
 For the behavioral analysis dissection, week by week, the 
two-way ANOVA followed by Bonferroni’s post-test was 
used. 
Only probability values (P) less than 0.05 were considered 
statistically significant. 
RESULTS 
Behavioral tests 
 Conditioned avoidance responses (CAR) of all animals 
registered one week after surgeries (Test 1, 67.2 ± 4.2%, n = 
23) were similar (P = 0.1311). Using One-way ANOVA we 
observed significant differences among the CAR of the four 
groups analyzed (F3,22 = 11.61, P < 0.001). Treatment 1 sig-
nificantly reduced the CAR for N-SA (36.0 ± 5.8%, n=6, 
P<0.01) when compared to the CAR observed for N-SC 
(73.2 ± 7.4%, n=5) (Fig. 1). These findings were not due to 
alterations in spontaneous motor activity, since no changes 
were observed in locomotion performance of all animals 
(data not shown). 
 Treatment 2 did not alter the CAR observed for N-SC 
and SC groups. Treatment 3, however, maintained the CAR 
for SA in values comparable to those obtained in Test 1 
(68.6 ± 7.9%, n=7). These values were significantly higher 
(P<0.01) when compared to those obtained for N-SA and 
not different from those obtained for SC (90.8 ± 1.8%, n=6) 
(Fig. 1). 
 
Fig. (1). Conditioned avoidance responses (CAR) of rats registered 
in an active avoidance apparatus. Vehicle-infused animals are rep-
resented in blanked histograms, while A-infused animals are rep-
resented in dark histograms bars. Histograms and vertical bars are 
means ± SEM. *:  < 0.05. 
 
 Dissection, week by week, of the behavioral analysis of 
stimulated groups 
 In order to better understand the animal’s behavior during 
the week rehearsal for sustained attention, we analyzed and 
compared the percentage of CAR in each of 10 trials of the 
50 total trials observed each week.  
 In week 1 animals from Control or A groups presented a 
significant difference in percentage of CAR (F4,64 = 3.32, P < 
0.05) along the fifth and fourth blocks of 10 trials, respec-
tively, showing that they learned the trial. For the control 
group, in the following submissions to the equipment no 
difference in percentage of CAR was observed, showing that 
they kept the memory of the task. However, the A group, in 
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the second week of observation, showed a lower percentage 
of CAR in the first 10 trials, which were significantly in-
creased along the subsequent trials (P < 0.05). In the last 
three weeks, despite the lower performance of A group, no 
statistical difference was verified between them and the con-
trol group (Fig. 2). 
Quantification of 7 nACh receptors 
 In the hippocampus of N-SC animals, specific binding 
sites for [125I]--BUTX were verified in pyramidal cells of 
CA1 area (Py: 0.3 ± 0.1 fmols/mg) and in the dentate gyrus 
(DG: 5.4 ± 0.6 fmols/mg). Other areas showed almost unde-
tectable specific binding sites. Treatment 1 significantly in-
creased the 7 density N-SA animals in Py (7.7 fold, P < 
0.05) and in DG (2.0 fold, P < 0.01) (Fig. 3, “a” and “b" and 
Fig. 3, panels “a” to “d”). In the same way, Treatment 2 sig-
nificantly increased [125I]--BUTX labeling in Py (14.3 fold, 
P < 0.001, Fig. 3a) and DG (3.3 fold, P < 0.001, Fig. 3b) of 
SC animals when compared to N-SC animals. After the 
stimulus, the SC group presented radioligand labeling (5.5 
fmols/mg) in the CA3 area (Fig. 3c and Fig. 4, panels “g” to 
“k”). After Treatment 3, SA group showed a significant 
increase in 7 density (1.8 fold, P < 0.001) only in the den-
tate gyrus (Fig. 3b), when compared to N-SA. No differ-
ence in 7 density between SC and SA was observed. 
 In the amygdala of N-SC animals, labeling for [125I]--
BUTX was verified in the lateral (0.9 ± 0.4 fmols/mg, Fig. 
5a), basolateral (1.3 ± 0.7 fmols/mg, Fig. 5b), basomedial 
(4.3 ± 1.2 fmols/mg, Fig. 5c), medial (2.1 ± 1.0 fmols/mg, 
Fig. 5d) and cortical (8.2 ± 1.0 fmols/mg, Fig. 5e) nuclei. 
Infusion of A peptide (Treatment 1) caused an increase in 
7 density in all nuclei (including central nucleus - Fig. 5f), 
but a significant increase was observed only in the baso-
lateral (5.0 fold, P < 0.01, Fig. 5b), medial (2.5 fold, P < 
0.05, Fig. 5d) and cortical (2.1 fold, P < 0.01, Fig. 5e) nuclei 
(see also Fig. 5 to autoradiography pseudocolor pictures). 
Different from what was observed in the hippocampus, 
Treatment 2 caused no difference in the 7 nAChR density 
in SC animals, when compared to N-SC group. In Treatment 
3, however, SA group presented significant increases in 
[125I]--BUTX labeling when compared to N-SA and SC 
groups in the lateral (2.0 fold, P < 0.001 and 2.6 fold, P < 
0.001, respectively), basolateral (1.4 fold, P < 0.05 and 3.2 
fold, P < 0.001, respectively) and basomedial (1.5 fold, P < 
0.05 and 3.2 fold, P < 0.001, respectively) nuclei (Fig. 5a, b, 
c, respectively). 
 Concerning the central nucleus, no labeling for [125I]--
BUTX was observed in N-SC animals (Fig. 5f and Fig. 6). 
Moreover, no difference in 7 receptor density was observed 
after any treatment applied. 
 Other areas directly related to memory that we also ob-
served labeling for [125I]--BUTX in N-SC animals were the 
frontal (1.7 ± 07.4 fmols/mg) and temporal (1.3 ± 0.5 
fmols/mg) cortices. After Treatment 1, no difference in 7 
density in these areas was observed. However, Treatment 2 
promoted significant increases in [125I]-BUTX binding of 2.0 
fold (P < 0.001) in the frontal cortex (Fig. 7 and 8) and 3.0
 
Fig. (2). Week dissection of conditioned avoidance responses (CAR) of Control and A animals submitted to rehearsal in the active avoid-
ance apparatus. For that, each 50 trials were divided in five groups of 10 trials. Histograms and vertical bars are means ± SEM. *:  < 0.05. 
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Fig. (3). Specific binding of [125I]--BUTX to 7 nicotinic cholinergic receptor in the pyramidal cells of CA1 area (a), dentate gyrus (b), 
CA3 (c) of hippocampus of the different animal groups. Data are presented as means ± SEM.*: P < 0.05; **: P < 0.01; ***: P< 0.001. 
 
 
Fig. (4). Pseudocolor photomicrographs of autoradiograms representing anatomical distribution of total binding sites for 7 nACh receptor in 
the pyramidal cells of CA1 area and in the dentate gyrus of hippocampus of non-stimulated control (N-SC, a), non-stimulated A (N-SA, b), 
stimulated control (SC, d) and stimulated A (SA, e) animals and also in the CA3 area of hippocampus of N-SC (g), N-SA (h), SC (j) and 
SA (k) animals. High level binding of the antagonist to the 7 receptor is shown in yellow/red, according to the scale. Non-specific binding 
sites are represented in “f” and “l”. Structures identification is represented on panels “c” and “i” (adapted from Paxinos and Watson, 2007). 
The antero-posterior levels are approximately -2.92 mm to panels “a”, “b”, “d” “e” and “f” and -4.44 mm to panels “g”, “h”, “j” “k” and “l”, 
with reference to bregma (Paxinos & Watson, 2007). Abbreviations: cc, corpus callosum; cg, cingulum; GrDG, granular layer of the dentate 
gyrus; PoDG, polymorph layer of the dentate gyrus; MoDG, molecular layer of the dentate gyrus; Py, pyramidal cell layer of the hippocam-
pus; fi, fimbria of the hippocampus; .LV, lateral ventricle; VG, ventral geniculate nycleus; ic, internal capsule; sox, supraoptic decussation; 
Or, oriens layer of the hippocampus; alv, alveus of the hippocampus; CA3, field CA3 of the hippocampus; SLu, stratum lucidum of the hip-
pocampus; Rad, radiatum layer of the hippocampus; AH, amygdalohippocampal area; BLP, basolateral amygdaloid nucleus, posterior part; 
Co, cortical amygdaloid nuclei, posterior part; APir, amygdalopiriform transition area; DEn, dorsal endopiriform nucleus; LVI, lamina VI of 
cortex. 
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Fig. (5). Specific binding of [125I]--BUTX to 7 nicotinic cholinergic receptor in the lateral (a), basolateral (b), basomedial (c), medial (d), 
cortical (e) and central (f) nuclei of the amygdala of the different animal groups. Data are presented as means ± SEM.*: P < 0.05; **: P < 
0.01; ***: P< 0.001. 
 
fold (P < 0.01) in the lamina VI of temporal cortex (Fig. 7 
and 4, in panels a, b, d and e) in SC animals. In the same 
way, Treatment 3 also promoted a significant increase in 7 
density in those areas (1.9 fold, P < 0.01 and 1.6 fold, P < 
0.05, respectively), when comparing to N-SA animals (1.8 
± 0.4 fmols/mg and 2.0 ± 0.4 fmols/mg, respectively). 
 Non-specific binding for [125I]--BUTX in all groups 
was 0.6 ± 0.1 fmols/mg. 
 
DISCUSSION 
 In the present work we observed that animals submitted 
to the chronic infusion of A peptide presented a significant 
decrease in memory retrieval, whereas weekly submissions 
of similar animals to the active avoidance test promoted a 
significant improvement in memory retention, despite the 
neurodegeneration in hippocampus and cortex caused by 
infusion of A (as we showed previously) [28]. This was 
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Fig. (6). Pseudocolor photomicrographs of autoradiograms representing anatomical distribution of total binding sites for 7 nACh receptor in 
the amygdala of N-SC (a), N-SA (b), SC (d) and SA (e) animals. High level binding of the antagonist to the 7 receptor is shown in yel-
low/red, according to the scale. Non-specific binding sites are represented in “f”. Structures identification are represented on panel “c” 
(adapted from Paxinos and Watson, 2007). The antero-posterior levels are approximately -2.92 mm to panels “a”, “b”, “d” “e” and “f”, with 
reference to bregma (Paxinos & Watson, 2007). Abbreviations: H, hypothalamus; LH, lateral hypothalamus; opt, optic tract; GP, globus pal-
lidum; CPu, caudate putamen (striatum); Ce, central amygdaloid nucleus; La, lateral amygdaloid nucleus; Me, medial amygdaloid nuclei; 
BM, basomedial amygdaloid nucleus; BL, basolateral amygdaloid nuclei; VEn, ventral endopiriform nucleus. For other abbreviations, refer to 
Figure 3. 
 
Fig. (7). Specific binding of [125I]--BUTX to 7 nicotinic cholinergic receptor in the frontal (a) and temporal (b) cortices of the different 
animal groups. Data are presented as means ± SEM.*: P < 0.05; **: P < 0.01; ***: P< 0.001. 
 
associated to increases in 7nAChR density in areas associ-
ated to memory formation and retention, such as the cortex, 
the hippocampus and the amygdala. The exact cell localiza-
tion of these increases (neuronal or glial cells) is being fur-
ther investigated by our group. 
RELATIONSHIP BETWEEN INCREASES IN  7 
DENSITY AND MEMORY MAINTENANCE  
 It is well known that memory formation circuits are very 
complex, involving several brain areas. Situations that in-
volve emotional requirement (like fear and stress, for in-
stance) are more probable to be stored as long term memory, 
once associative learning is a suitable way to reinforce long 
term potentiation (LTP) and, in this way, to learning and 
memory [18, 32]. 
 Two important brain areas related to this process are the 
amygdala and the hippocampus. The amygdala plays an im-
portant role in the connection of sensory information, par-
ticularly in relation to fear and anxiety, and promotes appro-
priate autonomic and behavioral reactions [33, 34]. It also 
has intensive interconnections with the hippocampal forma-
tion and cortical areas that are involved in memory process-
ing [17, 18, 35]. In this study, animals were weekly submit-
ted to an active avoidance apparatus. The fear-conditioning 
circuit implicated in this task involves the activation of neu-
rons from the amygdala basolateral complex [34, 36] and, as 
a result, animals present reactions related to fear or defense 
[18, 37]. In a recent work, our research team showed that 
C57Bl/6 mice as well as mice lacking bradykinin B1 or B2 
receptors showed an aging-related reduction response to this 
task [38]. 
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 Here, animals that were infused with vehicle (N-SC and 
SC) had the same performance in this behavioral test, inde-
pendent of the number of times they were submitted to the 
test. However, SC animals showed a significant increase in 
7 density in the hippocampus and the cortex, but not in the 
amygdala nuclei, when compared to the N-SC group. Appar-
ently, SC animals did not demand the fear-conditioning cir-
cuits to avoid the shock, since their areas related to attention 
and memory consolidation (cortex and hippocampus) were 
intact [28]. There is evidence that LTP occurs in Py and DG 
[39, 40] and also that 7 receptors are involved with this 
process [1, 3, 5].  
 The involvement of 7 nicotinic receptors in sustained 
attention has already been described using 7 KO mice [9, 
10] and rats treated with an 7 partial agonist (with 5-HT3 
antagonist actions) [11]. Taken together, these observations 
suggest that control animals learned and stored the informa-
tion they acquired during the intermittent submission to the 
active avoidance apparatus and that cholinergic neurons par-
ticipated in that process.  
 It was already shown by our research team and others 
that infusion of A peptide into rats’ lateral ventricle causes 
hippocampal and cortical neurodegeneration [28] and forma-
tion of amyloid plaques [41, 27] together with cognitive im-
pairment [26] and LTP disruption [42, 43]. Using the same 
protocol, the cognitive impairment was also observed in 
mice, showing that this effect is not species specific [29]. 
Concerning human reports, there have been contradictory 
data related to 7 nAChR expression in brains of AD pa-
tients. While some works showed an evident reduction in the 
density of this receptor, others showed an increase in 7 
nAChR- mRNA or no difference in [125I]--bungarotoxin 
binding (reviewed in [43] and [24]). The apparent contradic-
tion of the 7 nAChR density in brain areas of AD patients 
related to memory can be related to the fact that hippocampal 
and cortical neurons that express 7 nAChR seem to be 
more vulnerable to neurodegeneration, once there is evi-
dence that this receptor can bind to A peptide, leading to 
Ca2+ influx reduction, which contributes to cell death and 
cognitive impairment (for review, see [24]). However, there 
is suitable data that relate the increase in 7 nAChR to a 
non-defined compensatory mechanism of the brain [23, 24, 
62]. 
 We showed before that SA animals presented losses of 
cell bodies in hippocampal and cortical areas after infusion 
of A [28]. Here, we observed an increase of 7 receptors 
only in the DG concerning the hippocampus. However, a 
striking increase in the lateral, basolateral and basomedial 
nuclei of the amygdala was verified (when compared to both 
N-SA and SC). As discussed above, these three nuclei 
formed the basolateral complex of the amygdala, which re-
ceives the influence of many neurotransmitter systems, such 
as noradrenergic, cholinergic, glutamatergic and gabaergic 
[48-51] and is clearly related to the emotional modulation of 
 
Fig. (8). Pseudocolor photomicrographs of autoradiograms representing anatomical distribution of total binding sites for 7 nACh receptor 
in the frontal cortex of N-SC (a), N-SA (b), SC (d) and SA (e) animals. Non-specific binding sites are represented in “c”. Structures identi-
fication are represented on panel “f” (adapted from Paxinos and Watson, 2007). The antero-posterior levels are approximately 2,76 mm with 
reference to bregma (Paxinos & Watson, 2007). Abbreviations: DP, dorsal peduncular cortex; IL, infralimbic cortex; PrL, prelimbic cortex; 
Cg1, cingulate cortex, area 1; M1, primary motor cortex; M2, secondary motor cortex; Fr3, frontal cortex, area 3; S1J, primary somatosen-
sory cortex, jaw region; GI, granular insular cortex; DI, dysgranular insular cortex; AID, agranular insular cortex; LO, lateral orbital cortex; 
AcbC, accumbens nucleus, core; AcbSh, accumbens nucleus, shell; DEn, dorsal endopiriform nucleus; Pir, piriform cortex.  
1218    Current Alzheimer Research, 2012, Vol. 9, No. 10 Viel et al.
memory [34, 52]. The basolateral complex of the amygdala 
constitutes the entrance pathway for information that comes 
from sensorial stimulation (sound, light, shock, etc) [18, 53]. 
After that, it is transmitted to the central nucleus of the 
amygdala, which, in turn, projects it to areas of brain stem 
and hypothalamus that control defense behaviors, hormonal 
secretion and autonomic responses [37]. Interestingly, none 
of the animals showed labeling for 7 receptors in the cen-
tral nucleus of the amygdala, suggesting that this receptor is 
involved with the input of the information, but not in the 
efferent response. The cholinergic plasticity in amygdala was 
previously observed with the chronic exposure to nicotine 
[20] and there is evidence that formation and store of infor-
mation generated by fear conditioning in the amygdala also 
involve LTP [18, 19]. 
 Finally, an increase in 7 nAChR was observed in the 
hippocampus, frontal and temporal cortices, mainly in the 
lamina VI of stimulated animals. Lamina VI was shown to 
be a network for corticothalamic and corticocortical commu-
nications [54] and has been associated to cognitive functions 
[55, 56]. 
 Concerning the formation of LTP in hippocampus and in 
the amygdala, a probable pathway to explain the increase in 
7 density in these areas and also in the cortex involves the 
stabilization of these newly formed synapses by neurotro-
phins, mainly the brain-derived neurotrophic factor (BDNF). 
Among its numerous synaptic actions, BDNF is involved in 
the regulation of 7 nicotinic receptors in the hippocampus 
and in parasympathetic neurons [57-59]. In hippocampal 
cultures, it was demonstrated that BDNF increases both sur-
face and internal pools of 7nAChR and this increase is de-
pendent on glutamatergic activity [57, 59]. Also, the increase 
in 7 could happen in both pre and postsynaptic regions. In 
fact, it was already shown that presynaptic 7 can regulate 
glutamate release in hippocampus and other regions, whereas 
postsynaptic 7 down-regulate inhibitory GABAergic in-
terneurons activity necessary for long-term potentiation in 
the CA1 area of hippocampus [57, 59, 60, 61]. In addition to 
this, in recent findings from our group, C57Bl/6 mice were 
chronic infused with A together with the 7 antagonist 
methyllycaconitine (MLA) in the lateral ventricle and the 
same behavioral protocol described in the present work 
(week stimulation in an active avoidance apparatus) was 
used. It was observed that the memory maintenance was 
abolished, reinforcing the involvement of the 7 receptors in 
the memory process (unpublished data). Quantification of 
7, choline acetyltransferase and BDNF densities in brain 
areas of these animals are now being performed in our lab. 
 In conclusion, the observed increase in density of 7 
nAChR in the hippocampus, cortex and amygdala of stimu-
lated A animals can be related to a long-lasting modifica-
tion of the synapses which could contribute to the observed 
behavioral responses. 
INCREASES IN 7 DENSITY CAN ALSO BE RE-
LATED TO A CENTRAL ANTI-INFLAMMATORY 
PATHWAY 
 We also showed that chronic infusion with A peptide, 
per se, caused an increase in 7 nAChR density in some hip-
pocampal areas and some amygdala nuclei (as observed in 
N-SA). This was also observed in other brain areas, either 
related to memory processes or not (data not shown). This 
increase in 7 density could be taken as an anti-
inflammatory reaction to the presence of the A peptide. In 
fact it was shown that the treatment of microglia cell cultures 
with acetylcholine or nicotine caused an antiinflammatory 
response via NFB pathway [23, 44, 45]. This “nicotinic 
antiinflammatory pathway” was attributed to be dependent 
on the 7 nAChR, once the effect was attenuated with the 
antagonist -bungarotoxin [23]. Similar observations were 
made in rats pre-treated with MLA and the anticholinestera-
sic agent donepezil and then, submitted to lipopolysaccha-
ride (LPS) intracerebroventricular injection. MLA, but not 
dihydro--erytroidine (an 42 receptor antagonist) or sco-
polamine (a muscarinic receptor antagonist) reduced the anti-
inflammatory effect of donepezil [46], showing, once again, 
the participation of 7 nAChR in the efferent way of the 
inflammatory reflex, which also involves the efferent vagus 
nerve and, obviously, the neurotransmitter acetylcholine 
[47]. This possible antiinflammatory reaction is being further 
investigated by our research team. 
CONCLUSION 
 Sustained attention and A infusion increased cholinergic 
neurotransmission in the cortex, the hippocampus and the 
amygdala via, at least, increases in 7 nAChR density. In 
agreement to other published articles, this might be involved 
with a modulation of the cholinergic system to induce LTP, 
leading to improvement of neuroprotection and memory 
maintenance. However, a compensatory mechanism pro-
moted by the increase in 7 receptor density to avoid the 
neuroinflammatory process associated with the A deposits 
was not discarded. 
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